Japan's Bushu Pharmaceuticals Ltd. has entered into a business alliance agreement with Suzuken Co., Ltd. to offer a service that provides comprehensive support for new product launches for specialty pharmaceutical manufacturers looking to enter the Japanese market.

In recent years, the number of innovative specialty pharmaceuticals on the market, such as biopharmaceuticals, regenerative medicines, and orphan drugs for rare diseases, that require strict temperature, inventory, and security control has been increasing.

In line with this trend, the number of pharmaceutical manufacturers aiming to introduce these types of products to Japan has been increasing as well. These pharmaceutical manufacturers, however, frequently do not have the required assets such as manufacturing plants, distribution centers and networks necessary to enter the Japanese market with minimal resources and, therefore, must outsource these functions to entrusted partners.

Bushu Pharma's partner, Suzuken, has played an industry-leading role in the pharmaceutical distribution sector in Japan. Suzuken, one of the largest companies in that sector, possesses a distribution network in Japan that can support the international transportation of specialty pharmaceuticals.

On the other hand, Bushu Pharma has been engaged in the contract manufacturing business in Japan for more than 20 years, holds GMP certifications from all over the world, and has a track record of exporting to more than 43 countries. By aligning functions and capabilities with Suzuken, Bushu Pharma will create a platform that enables one-stop comprehensive support for pharmaceutical manufacturers looking to enter the Japanese market.